Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

16.07USD
8 Feb 2016
Change (% chg)

$-0.55 (-3.31%)
Prev Close
$16.62
Open
$16.45
Day's High
$16.50
Day's Low
$15.68
Volume
3,314,839
Avg. Vol
2,362,526
52-wk High
$19.06
52-wk Low
$14.18

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $22,357.14
Shares Outstanding(Mil.): 1,345.19
Dividend: --
Yield (%): --

Financials

Search Stocks

UPDATE 2-Heart device maker Boston Scientific's sales miss estimates

* Shares fall as much as 6 pct (Adds conference call details, analyst comment, background, shares)

04 Feb 2016

Boston Scientific reports 4.8 pct rise in quarterly revenue

Feb 4 Medical device maker Boston Scientific Corp reported a 4.8 percent rise in quarterly revenue, boosted by higher sales in its surgical equipment unit.

04 Feb 2016

UPDATE 2-Boston Scientific profit beats Street on demand for surgical products

* Shares up 4 pct in light premarket trading (Adds forecast)

28 Oct 2015

Boston Scientific's revenue rises about 2 pct

Oct 28 Medical device maker Boston Scientific Corp reported a 2.3 percent rise in quarterly revenue as sales rose in all three of its divisions.

28 Oct 2015

Boston Scientific mesh verdict slashed to $10 million

NEW YORK A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvaginal mesh, a device that is the subject of thousands of lawsuits.

09 Oct 2015

Boston Scientific mesh verdict slashed to $10 million

NEW YORK, Oct 9 A Delaware judge on Friday said Boston Scientific should only have to pay $10 million to a woman originally awarded $100 million by a jury who found she was injured by transvaginal mesh, a device that is the subject of thousands of lawsuits.

09 Oct 2015

Boston Scientific's stent approved for peripheral artery disease

Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments.

20 Aug 2015

UPDATE 1-Boston Scientific's stent approved for peripheral artery disease

Aug 19 Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the country due to partial or no deployments.

20 Aug 2015

Special Report - Investors profit by funding surgery for desperate women patients

NEW YORK In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. Fisher was looking for surgeons to perform operations to remove pelvic mesh implants from women.

18 Aug 2015

SPECIAL REPORT-Investors profit by funding surgery for desperate women patients

NEW YORK, Aug 18 In July 2013, California urogynecologist Andrew Cassidenti received an email from an entrepreneur named Otto Fisher, who had a proposition. Fisher was looking for surgeons to perform operations to remove pelvic mesh implants from women.

18 Aug 2015

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $37.46 +0.05
St. Jude Medical, Inc. (STJ.N) $50.30 -0.91

Earnings vs. Estimates

Search Stocks